Frank Wollheim
1 – 50 of 80
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Response to : 'Correspondence on 'Jan Gösta Waldenströmand rheumatology'' by Moutsopoulos
(
- Contribution to journal › Letter
-
Mark
Nanna Svartz (1890-1986) and the discovery of sulfasalazine
(
- Contribution to journal › Article
- 2020
-
Mark
Ralph C Williams Jr and the world of rheumatology : a tribute from Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
(
- Contribution to journal › Letter
-
Mark
Jan Gösta Waldenström and rheumatology
(
- Contribution to journal › Article
- 2018
-
Mark
There is a need for new systemic sclerosis subset criteria. A content analytic approach
(
- Contribution to journal › Article
- 2017
-
Mark
Nanna Svartz (1890–1986) : Die erste Frau auf einem medizinischen Lehrstuhl in Schweden
(
- Contribution to journal › Article
-
Mark
T-regulatory cells-Triumph of perseverance : The Crafoord Prize for Polyarthritis in 2017
(
- Contribution to journal › Article
-
Mark
Les télocytes, communicateurs dans le stroma sain et lien avec l’inflammation et la fibrose
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Systemic sclerosis
2017) p.165-178(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Diet induced arthritis in pigs: Comment on the Article by Scher et al.
(
- Contribution to journal › Letter
-
Mark
Telocytes, communicators in healthy stroma and relation to inflammation and fibrosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Universitetsenheterna i reumatologi i Lund och Malmö : Historia med Ido
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
“United we win”, communication is the key for a better future in scleroderma
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Collagenous colitis in systemic sclerosis: an overlooked and treatable complication.
(
- Contribution to journal › Article
-
Mark
International consensus criteria for the diagnosis of Raynaud's phenomenon.
(
- Contribution to journal › Article
- 2013
-
Mark
The Crafoord Prize in polyarthritis 2013.
2013) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Messages from the morgue to rheumatology: from Chagas disease to giant cell arteritis.
(
- Contribution to journal › Article
-
Mark
The Crafoord Prize in Polyarthritis 2013: Significant discoveries and remaining challenges.
(
- Contribution to journal › Debate/Note/Editorial
- 2011
-
Mark
Advances in CTDs What has been done and what is out there?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Introduction - Microorganisms and the locomotor system.
(
- Contribution to journal › Article
- 2010
-
Mark
Cellular Factor Xiii And Peptidylarginine Deiminase-Catalysed Citrullination In Rheumatoid Arthritis
2010) 30th European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 69(Suppl. 2).(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease.
(
- Contribution to journal › Article
- 2008
-
Mark
A pain in the knee - is it osteoarthritis?
(
- Contribution to journal › Debate/Note/Editorial
- 2007
-
Mark
Prescription of glucosamine for osteoarthritis: does it work and is it safe?
(
- Contribution to journal › Letter
-
Mark
Treatment of pulmonary fibrosis in systemic sclerosis: Light at the end of the tunnel?
(
- Contribution to journal › Letter
-
Mark
Management of intestinal involvement in systemic sclerosis.
(
- Contribution to journal › Letter
-
Mark
Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease
(
- Contribution to journal › Article
-
Mark
Pathology and animal models of osteoarthritis
2007) p.104-104(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2006
-
Mark
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Are occupational risk factors associated with markers of disease severity in patients with systemic scleroderma?
(
- Contribution to journal › Article
- 2005
-
Mark
The 5th annual European league against rheumatism congress in Berlin: A personal perspective
(
- Contribution to journal › Letter
-
Mark
Aspects of science in Scandinavian rheumatology the making of a specialty.
(
- Contribution to journal › Scientific review
-
Mark
Classification of systemic sclerosis. Visions and reality.
(
- Contribution to journal › Scientific review
- 2004
-
Mark
The 4th annual European League Against Rheumatism congress in Lisbon: a personal perspective.
(
- Contribution to journal › Article
-
Mark
Scleroderma renal crisis: the sword of damocles.
(
- Contribution to journal › Letter
-
Mark
Is Rituximab a Potential New Therapy in Systemic Sclerosis?: New Evidence Indicates the Presence of CD20-Positive B-lymphocytes in Scleroderma Skin.
(
- Contribution to journal › Letter
-
Mark
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis
(
- Contribution to journal › Article
- 2003
-
Mark
Genetics and susceptibility to RA - More than HLA
(
- Contribution to journal › Letter
-
Mark
European collaboration at its best: 23rd European Workshop for Rheumatology Research.
(
- Contribution to journal › Article
-
Mark
Drug resistance in rheumatology: an area in search of investigators.
(
- Contribution to journal › Article
-
Mark
Early stages of osteoarthritis: the search for sensitive predictors
(
- Contribution to journal › Article
-
Mark
Cyclosporin A in rheumatoid arthritis
(
- Contribution to journal › Letter
-
Mark
Die Osteoarthritis (Arthrose) geht uns alle an
(
- Contribution to journal › Letter
- 2002
-
Mark
Osteoarthritis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Validecoxib - A viewpoint by Frank A. Wollheim
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Long term efficacy and safety of cyclosporin versus parenteral old in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension
(
- Contribution to journal › Article
-
Mark
TNF inhibition as therapy for rheumatoid arthritis.
(
- Contribution to journal › Scientific review
-
Mark
Remicade in der Therapie der rheumatoiden Arthritis und des Morbus Crohn - Kein Grund zur Panik
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CLASS-studien och dess vetenskapliga redovisning. Etiska regler för publicering åsidosatta
(
- Contribution to journal › Article